A detailed history of Rfp Financial Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rfp Financial Group LLC holds 187 shares of GILD stock, worth $15,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187
Previous 226 17.26%
Holding current value
$15,818
Previous $16,000 25.0%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$63.15 - $72.88 $2,462 - $2,842
-39 Reduced 17.26%
187 $12,000
Q1 2024

May 09, 2024

SELL
$71.58 - $87.29 $4,080 - $4,975
-57 Reduced 20.14%
226 $16,000
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $4,835 - $5,483
66 Added 30.41%
283 $22,000
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $380 - $433
5 Added 2.36%
217 $16,000
Q1 2023

Apr 26, 2023

SELL
$77.31 - $88.08 $386 - $440
-5 Reduced 2.3%
212 $17.6 Million
Q4 2022

Jan 24, 2023

BUY
$62.32 - $89.47 $13,523 - $19,414
217 New
217 $18.6 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $106B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Rfp Financial Group LLC Portfolio

Follow Rfp Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfp Financial Group LLC with notifications on news.